Rivaroxaban Plus Aspirin Versus Standard Dual Antiplatelet Therapy Following Angioplasty for Lower Extremity Peripheral Arterial Disease in Patients With Critical Limb Ischemia and Claudication (RIVAL-PAD): 12-Month Results of a Randomized Trial
JOURNAL OF VASCULAR SURGERY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要